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Abstract
Background/Objectives: In this data brief, we examine major eye and ear anomalies 
(anophthalmia/microphthalmia, anotia/microtia, and congenital cataract) for a recent 5-year birth 
cohort using data from 30 population-based birth defects surveillance programs in the United 
States.
Methods: As a special call for data for the 2018 NBDPN Annual Report, state programs reported 
expanded data on eye/ear anomalies for birth years 2011–2015. We calculated the combined 
overall prevalence (per 10,000 live births) and 95% confidence intervals (CI), for the three 
anomalies as well as by maternal age, maternal race/ethnicity, infant sex, laterality, presence/
absence of other major birth defects, and case ascertainment methodology utilized by the program 
(active vs. passive).
Results: The overall prevalence estimate (per 10,000 live births) was 1.5 (95% CI: 1.4–1.5) for 
anophthalmia/microphthalmia, 1.5 (95% CI: 1.4–1.6) for congenital cataract, and 1.8 (95% CI: 
1.7–1.8) for anotia/microtia. Congenital cataract prevalence varied little by maternal race/ethnicity, 
infant sex, or case ascertainment methodology; prevalence differences were more apparent across 
strata for anophthalmia/microphthalmia and anotia/microtia. Prevalence among active vs. passive 
ascertainment programs was 50% higher for anophthalmia/microphthalmia (1.9 vs. 1.2) and two-
fold higher for anotia/microtia (2.6 vs. 1.2). Anophthalmia/microphthalmia was more likely than 
other conditions to co-occur with other birth defects. All conditions were more frequent among 
older mothers (40+ years).
Conclusions: This data brief provides recent prevalence estimates for anophthalmia/
microphthalmia, congenital cataract, and anotia/microtia that address a data gap by examining 
pooled data from 30 population-based surveillance systems, covering a five-year birth cohort of 
about 12.4 million births.
Keywords
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based surveillance
1 | INTRODUCTION
The National Birth Defects Prevention Network (NBDPN) has collaborated with population-
based birth defects surveillance programs in the United States and the Centers for Disease 
Control and Prevention (CDC) annually since 2000 to publish state-level data on major 
structural birth defects as part of the Congenital Malformations Surveillance Report. The 
NBDPN updated the list of major birth defects in 2014 after a thorough review of 
conditions. Defects included on the list are those with high public health importance, those 
that are generally diagnosed within the first year of life, those amenable to potential 
prevention/intervention strategies, and those that can be monitored as a separate condition 
(Mai et al., 2014).
The 2018 NBDPN Congenital Malformations Surveillance Report includes state-specific 
birth defects counts and prevalence estimates from 41 population-based birth defects 
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surveillance systems, reporting up to 47 major birth defects covering the central nervous 
system, eye and ear, cardiovascular system, gastrointestinal system, genitourinary system, 
musculoskeletal system, as well as chromosomal conditions, described in Table 1. A 
program directory is included to describe individual population-based birth defects 
programs, available on pages [S123-S177]. The directory covers each program’s case 
definition, surveillance methodology, sources of birth defects information, data collection 
procedures, and program contacts. Finally, the NBDPN report features a data brief that pools 
data from 30 surveillance programs to provide a more detailed description of eye and ear 
anomalies.
2 | STATE-SPECIFIC DATA COLLECTION AND PRESENTATION OF 47 
MAJOR BIRTH DEFECTS
2.1 | Data collection
The NBDPN Data Committee, in collaboration with the CDC, issued a call for data to state 
and territorial birth defects surveillance programs to report birth defects cases for a birth 
cohort beginning with January 1, 2011 and end-ing with December 31, 2015. The call for 
data included instructions and a data dictionary for each of the major birth defects on the 
NBDPN list (Table 1) by year of birth, maternal race/ethnicity, maternal age at delivery, and 
infant sex. Maternal race/ethnicity was stratified by U.S. Census group: non-Hispanic white, 
non-Hispanic black, Hispanic, non-Hispanic Asian/Pacific Islander, non-Hispanic American 
Indian/Alaska Native, and other/unknown. Maternal age at delivery was stratified by the 
following age groups: < 20, 20–24, 25–29, 30–34, 35–39, ≥40 years of age, and unknown. 
Infant sex was collected as male, female, and unknown.
A sample SAS file and an Excel template were provided to state programs to aid with data 
submission. In addition, a PDF fillable directory with prepopulated responses about each 
program (from their previous submission) was provided for program review and updates. 
Following data and directory profile submission to CDC for central cleaning and processing 
using SAS 9.4 (Cary, NC), CDC staff worked with state programs to review and validate the 
submitted information. Review and approval by state birth defects programs were completed 
prior to final creation of data tables and directory profiles.
2.2 | Data presentation
A total of 41 state and territorial birth defects surveillance programs submitted data for this 
NBDPN Data Report. Data for the birth cohort 2011–2015 are presented in two separate 
tables for each state/territorial surveillance program (Supporting Information). The first table 
for each surveillance program displays counts and prevalence (per 10,000 live births) by five 
maternal racial/ethnic groups. The second table presents counts and prevalence by two 
maternal age categories (<35 years, ≥35 years) for gastroschisis and trisomies 13, 18, and 
21. Maternal age groups were collapsed from six categories into two larger age groups to 
ensure adequate cell counts. The prev-alence for all defects (excluding congenital posterior 
SUPPORTING INFORMATION
Additional supporting information may be found online in the Supporting Information section at the end of the article.
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urethral valves [CPUV], hypospadias, and Turner syndrome) was calculated as the count of 
cases within each stratum of a maternal or child characteristic—regardless of pregnancy 
outcome (i.e., live birth, stillbirth, spontaneous/elective termination)— divided by the total 
number of live births within the same stratum (Mason, Kirby, Sever, & Langlois, 2005). It is 
presented as prevalence per 10,000 total live births. For CPUV and hypospadias, the 
prevalence is per 10,000 male live births; for Turner syndrome, it is per 10,000 female live 
births.
To address variations in surveillance methodology, footnotes accompany each table to 
describe differences in case inclusion criteria, data sources, coding system(s) used, and/or 
case ascertainment methodology. The program directory in the Supporting Information 
contains more in-depth information on each program’s data collection methods and potential 
sources of variation.
3 | DATA BRIEF ON EYE AND EAR ANOMALIES
3.1 | Background
The featured data brief for the 2018 Data Report focus on eye and ear anomalies, 
specifically anophthalmia/micro-phthalmia, congenital cataract, and anotia/microtia for birth 
years 2011–2015. Studies estimating the prevalence of major eye and ear anomalies from 
large-scale population-based data are limited. This brief provides an opportunity to examine 
the prevalence of these major eye and ear anomalies from population-based surveillance 
systems across the United States for a recent birth cohort.
3.1.1 | Eye anomalies—Anophthalmia/microphthalmia and congenital cataract are 
common defects of the eye. Anophthalmia is the total absence of eye tissue or apparent 
absence of the globe in an otherwise normal orbit, whereas microphthalmia is defined by a 
reduced volume of the eye (the corneal diameter is usually <10 mm, or the anteroposterior 
globe diameter is <20 mm) (NBDPN, 2015). Congenital cataract is an opacity of the lens of 
the eye that has its origin prenatally (NBDPN, 2015). It is a common cause of preventable 
blindness in children (Gilbert & Foster, 2001).
Reported prevalence of anophthalmia/microphthalmia ranges from 1.87 per 10,000 births 
(Parker et al., 2010) to 3.00 per 10,000 births (Chambers et al., 2018). Bhatti et al. (2003) 
reported the prevalence of congenital cataract to be 2.03 per 10,000 births. In a 2010 case-
control study, Pra-kalapakorn, Rasmussen, Lambert, and Honein (2010) reported 59% of 
congenital cataract cases had bilateral cataracts and 41% unilateral.
Anophthalmia/microphthalmia appears to be associated with some maternal and infant 
factors. For instance, it has been reported that the birth prevalence of these defects increases 
with advanced maternal age (Kallen & Tornqvist, 2005; Shaw et al., 2005). In addition, 
mothers of infants born with anophthalmia/microphthalmia or congenital cataract are more 
likely to be of lower socioeconomic status, unmarried, unemployed, and have fewer years of 
education (i.e., <12 years) (Puho, Vogt, Csaky-Szunyogh, Metneki, & Czeizel, 2008; Shaw 
et al., 2005). The risk for these conditions, especially bilateral microphthalmia, increases 
with multifetal pregnancies and higher parity (Shaw et al., 2005).
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The prevalence of these defects has also been observed to differ by infant sex. For instance, 
the prevalence of anophthalmia/microphthalmia is higher in females than in males (Forrester 
& Merz, 2006). Haargaard, Wohlfahrt, Rosenberg, Fledelius, and Melbye (2005) reported 
that cases of bilateral isolated cataract were predominately male while unilateral isolated 
cases were predominately female.
A majority of anophthalmia/microphthalmia cases are associated with other congenital 
malformations. These primarily include anomalies of the central nervous system, facial 
anomalies, cardiovascular anomalies, chromosomal abnormalities, and musculoskeletal/limb 
anomalies. Cham-bers et al. (2018) found more than half (55.7%) of cases of anophthalmia/
microphthalmia also had a chromosomal abnormality or syndrome, most commonly trisomy 
13 or 21. That study also reported that 92.4% of nonsyndromic cases (i.e., without a known 
chromosomal abnormality or genetic syndrome) had at least one additional co-occurring 
birth defect (Chambers et al., 2018). In contrast, Bhatti et al. (2003) found that about a 
quarter of congenital cataract cases (22%) occur as part of a syndrome—most commonly 
trisomy 13—and another 20% occurred in conjunction with other birth defects.
3.1.2 | Ear anomalies—Defects of the ear include anotia (total absence of the external 
ear and canal) and microtia (malformation or hypoplasia of the external ear) (NBDPN, 
2015). The prevalence of these conditions is approximately 3.06 per 10,000 live births, with 
a higher prevalence of isolated cases compared to those that occur with other defects or as 
part of a syndrome (Deng et al., 2016). Unilateral microtia, especially right-sided microtia, 
is the most common form (Yamauchi et al., 2012). Compared to the eye anomalies evaluated 
in this data brief, there are substantial racial differences for anotia/microtia. Anotia/microtia 
occurs more frequently among infants born to Hispanic mothers, either U.S.- or foreign-
born, as well as infants born to American Indian/Alaska Native, Filipino and Chinese 
mothers when compared to other racial/ethnic groups (Hoyt et al., 2014; Canfield et al., 
2014; Canfield, Langlois, Nguyen, & Scheuerle, 2009). Similar to defects of the eye, the 
prevalence of anotia/microtia increases with higher maternal age and lower maternal 
education (Canfield et al., 2009; Deng et al., 2016). In addition, anotia/microtia is more 
common among males, especially in isolated forms (Yamauchi et al., 2012).
Anotia and microtia are also associated with other congenital malformations. The most 
common associations are found in the craniofacial region, cardiovascular system, and 
musculoskeletal system, with the proportion of cooccurrence for craniofacial and limb 
defects increasing as the severity of the microtia increases (Luquetti et al., 2013; Yamauchi 
et al., 2012). More specifically, microtia is often accompanied by congenital heart defects, 
cleft lip and/or palate, vertebral defects, and anomalies of the extremities. Multiple 
malformations among infants with anotia/microtia are associated with low birthweight and 
increased maternal age (Yamauchi et al., 2012).
Because of the combined prevalence and impact of these conditions and limited recent 
studies, we wanted to examine the differences in the birth prevalence of these conditions by 
key characteristics, such as maternal race/ethnicity, maternal age, and infant sex.
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3.2 | Methods
As a special call for data for the 2018 NBDPN Annual Report, state programs were invited 
to report expanded data on eye and ear anomalies. The specific codes for anophthalmia/
microphthalmia, congenital cataract, and anotia/microtia is provided in Table 1. Data 
requested included case-level information by year of birth, maternal race/ethnicity, maternal 
age at delivery, infant sex, laterality (either in specific CDC/BPA code or as a separate field), 
and co-occurring birth defects. Programs were asked to submit information on any co-
occurring birth defects they collect, including major and minor defects; however, this report 
presents co-occurring congenital anomalies grouped by organ system, as specified by 
ICD-9-CM codes (740–759 - congenital anomalies) and ICD-10-CM codes (Q00-Q99—
congenital malformations, deformations, and chromosomal abnormalities), and excludes any 
birth defects codes outside these ranges. The data submission process and review followed a 
similar approach to the main annual report data submission. CDC obtained a nonresearch 
determination for the project.
Analyses were performed using SAS 9.4 (Cary). The 95% confidence intervals were 
calculated using exact Poisson methodology for prevalence estimates and exact binomial for 
measures of percent (Daly, 1992). Prevalence estimates are reported as the number of cases 
per 10,000 live births. A second CDC analyst validated the results presented in the tables.
4 | RESULTS
A total of 30 state and territorial birth defects surveillance programs, covering a total of 
12,441,847 births from 2011 to 2015, provided expanded data for eye and ear anomalies. 
Table 2 presents the counts and birth prevalence for eye and ear anomalies by case 
ascertainment methodology, maternal race/ethnicity, maternal age, and infant sex. Pooling 
data from all 30 participating surveillance programs, the prevalence estimates (per 10,000 
live births) were: 1.5 for anophthalmia/microphthalmia (1,785 cases), 1.5 for congenital 
cataract (1,818 cases), and 1.8 for anotia/microtia (2,206 cases).
Prevalence estimates per 10,000 live births were consistent by case ascertainment 
methodology for congenital cataract, but differences were seen when comparing case 
ascertainment methodology for anophthalmia/microphthalmia (1.9 for active versus 1.2 for 
passive) and for anotia/ microtia (2.6 for active versus 1.2 for passive).
Variations in prevalence were observed among maternal racial/ethnic groups (Table 2), with 
infants born to Hispanic and non-Hispanic American Indian/Alaska Native mothers having 
the highest prevalence (per 10,000) of anophthalmia/microphthalmia (both 1.9) and infants 
born to Hispanic mothers having the highest prevalence of anotia/microtia (3.6). For anotia/
microtia, infants born to non-Hispanic American Indian/Alaska Native (2.6) and non-
Hispanic Asian/Pacific Islander (2.4) mothers also had higher prevalence than other maternal 
racial/ethnic groups while the prevalence among infants born to non-Hispanic black mothers 
was substantially lower than other groups (0.8). Conversely, little variation among maternal 
racial/ethnic group was observed for congenital cataract cases.
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When evaluating differences in prevalence by maternal age for all three conditions, the 
highest estimates (per 10,000 live births) were observed among infants born to mothers who 
were 40+ years of age at the time of delivery (3.7 for anophthalmia/microphthalmia, 2.5 for 
congenital cataract, and 3.2 for anotia/microtia).
Prevalence estimates (per 10,000 live births) were similar by infant sex for congenital 
cataract, but anophthalmia/ microphthalmia was more prevalent in females compared to 
males (1.6 vs. 1.4, respectively) and anotia/microtia was more prevalent in males (1.9 vs. 
1.6) (Table 2).
Thirteen of the 30 state and territorial surveillance programs contributing data to the data 
brief were able to report laterality information for these defects. Table 3 presents laterality 
(unilateral and bilateral)—with unilaterality further divided into left, right, and not specified
—for the eye and ear anomalies. Cases of congenital cataract were similarly split between 
unilateral and bilateral, although 23.0% were reported to be unknown laterality or were 
reported as anterior polar (i.e., had no laterality assigned). For anophthalmia/
microphthalmia, 61.3% of cases were reported as bilateral compared to 38.7% unilateral 
cases, while the inverse was observed for anotia/microtia (79.0% unilateral cases versus 
21.0% bilateral cases). The unilateral cases for anophthalmia/microphthalmia were similarly 
split between left and right, but for anotia/microtia more unilateral right cases (49.2%) were 
reported compared to unilateral left cases (29.5%).
Table 4 displays co-occurring birth defects by organ system for the eye and ear anomalies. 
Co-occurring birth defects were most commonly observed among children with 
anophthalmia/microphthalmia (74.1%), intermediate for anotia/microtia cases (53.6%) and 
least frequent among congenital cataract cases (35.9%). Cardiovascular defects represented 
the most common co-occurring group of birth defects for all three conditions (43.0% of 
anophthalmia/microphthalmia cases, 18.8% of congenital cataract cases, and 27.7% of 
anotia/microtia cases). A large proportion of anophthalmia/microphthalmia cases had co-
occurring ear, face, and/or neck defects (34.2%), musculoskeletal and/or limb defects 
(25.2% musculoskeletal, 28.9% limbs, and 29.4% other musculoskeletal), and/or 
chromosomal conditions (29.1%). Anotia/microtia cases also showed a moderate proportion 
of co-occurring musculoskeletal and limb defects (14.2% musculoskeletal, 11.8% limbs, and 
23.3% other musculoskeletal).
5 | DISCUSSION
This report provides recent population-based prevalence estimates for eye and ear anomalies 
for a cohort of about 12.4 million births from 30 surveillance systems in the United States. 
In addition, our analysis provides new data on cooccurrence with other congenital anomalies 
by organ system.
The prevalence estimates presented in this data brief for all three conditions are lower than 
some previously reported in the literature (Bhatti et al., 2003; Chambers et al., 2018; Deng et 
al., 2016; Parker et al., 2010) but estimates for anophthalmia/microphthalmia and anotia/
microtia are higher than what was reported in the 2015 NBDPN Annual Report data brief 
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(Mai et al., 2015). The overall prevalence for congenital cataract we observed is similar to 
that found in the 2015 report; however, the 2015 report shows a difference in cataract 
prevalence by case ascertainment methodology while our new prevalence estimates do not 
show a similar difference (Mai et al., 2015). Variations can be expected given different 
cohort periods, but another contributing factor might be variations in how the conditions are 
ascertained. As anophthalmia/microphthalmia and anotia/microtia include a range of 
severity, a wider range of prevalence estimates can be observed compared to a condition 
with a narrow range of severity, such as congenital cataract, where the estimates appear to be 
more consistent across programs and birth cohort periods.
Our results show a slightly higher proportion of anotia/ microtia with co-occurring defects 
compared to isolated ano-tia/microtia. This is different from what was observed by Deng et 
al. (2016), who found a higher prevalence of isolated anotia/microtia. Our inclusion of the 
entire range of congenital structural malformations ICD-9-CM/ICD-10-CM codes, which 
likely include a more heterogeneous group of structural malformations, could be the 
explanation for this difference. We evaluated co-occurrence by organ system for active and 
passive case-finding programs separately and found a similar proportion of co-occurring 
defects for all three eye/ear anomalies regardless of case-ascertainment methodology (data 
not shown).
Our results are similar to previous analyses of anotia/microtia with respect to the unilateral 
versus bilateral and left-right unilateral presentation, as well as prevalence by infant sex 
(Yamauchi et al., 2012). However, while a case-control study by Prakalapakorn et al. (2010) 
found a higher proportion of bilateral congenital cataract cases compared to unilateral cases, 
our results show a more even division for bilateral and unilateral cases.
Consistent with previous reports, the vast majority of anophthalmia/microphthalmia cases 
co-occurred with other birth defects (74.1%). Some of the commonly affected organ systems 
include ear/face/neck, musculoskeletal system, central nervous system anomalies, and 
cardiovascular defects. However, variations were observed by degree of cooccurrence among 
the studies, most likely due to inclusion criteria. For example, our results showed a higher 
proportion of cardiac conditions than Chambers et al. (2018). This could be due to cardiac 
conditions occurring as part of chromosomal syndromes; however, we decided not to remove 
chromosomal abnormalities to be able to present a complete description of all cases.
This report has several limitations. Variations in case ascertainment methodology and 
anomalies collected by the different state/territorial programs could contribute to variations 
in the quantity and range of co-occurring conditions reported. Some programs provided a 
more comprehensive list of co-occurring conditions while other programs captured a 
narrower list of conditions. The birth defects we evaluated for co-occurrence were also 
limited to the congenital anomalies range of ICD-9-CM codes and the congenital 
malformations, deformations, and chromosomal abnormalities range of ICD-10-CM. As a 
result, conditions that potentially may be considered congenital anomalies outside these 
ranges are excluded. However, by restricting the code range, the co-occurring data presented 
are more consistent across programs.
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Our results are limited to cases with known laterality. For congenital cataract, it is unclear 
how the high percentage of unknown or unspecified cases (including several anterior polar 
cases where laterality could not be assigned) may have affected the reported proportions of 
laterality for this condition.
Finally, some state/territorial surveillance programs report recent years (mainly 2015) of 
their surveillance data as provisional. In October 2015, the coding system transitioned from 
ICD-9-CM to ICD-10-CM. An evaluation is in process to determine which conditions might 
have been affected by the transition, but we expect minimal impact for this report as this 
affects only 5% of the birth cohort (three out of 60 months of data).
6 | CONCLUSION
The 2018 NBDPN Congenital Malformations Surveillance Report includes data from 41 
state and territorial population-based birth defect surveillance programs, reporting up to 47 
major birth defects. The report continues to provide important and updated information on 
the occurrence of major birth defects in the United States. This year’s data brief on eye and 
ear anomalies, using pooled surveillance data from 30 states, provide population-based 
prevalence estimates along with data on co-occurrence with conditions by organ system for a 
cohort of about 12.4 million births. The updated prevalence estimates for anophthalmia/
microphthalmia, congenital cataract, and anotia/microtia may provide a basis for future 
epidemiologic studies to better understand the impact of these conditions.
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